Skip to main content

Why does the gamma camera sit idle in the middle of the morning?

The gap between the last injection and the first delayed image is built into the tracers, not into the department. How to fill it with studies that image immediately, and the five places a nuclear medicine list actually breaks down.

Stand in a nuclear medicine department at half past nine and the camera is often empty, with a full waiting room outside it. The morning's bone scans were injected between eight and nine and none of them can be imaged for another two hours. The department is busy and the camera is not, and a board looking at utilisation figures reads that as a staffing problem or a marketing problem when it is neither.

The gap is built into the tracers

Delayed studies dominate most lists, and each has an uptake interval fixed by biology rather than by convenience. A bone agent needs a couple of hours to clear soft tissue. A renal cortical study needs several. Radioiodine uptake measurements are made at set intervals that run into the following day. None of that is negotiable, and shortening it to fit the timetable produces images that get reported with a caveat.

So the working day has a shape. Injections cluster early, delayed imaging clusters late morning and afternoon, and between the two there is a window during which the camera has nothing booked. The window is not waste. It is only waste if nothing is put in it.

Filling it with the studies that do not wait

Some studies image from the moment of injection or within minutes of it. Those belong in the gap, and building the weekly template around that single idea recovers most of the lost capacity.

There is a second constraint that is chemical rather than clinical, and departments schedule against it without always naming it. The generator is eluted in the morning and the eluate decays through the day, so the same prescribed activity needs a larger volume by three in the afternoon than it did at nine. Put the studies with the highest administered activity early and the low activity work later, and the elution goes further. The supply side of that arithmetic is in radiopharmaceutical supply and logistics.

Where the list actually breaks

A template that works on paper fails in the same five places, and none of them is the camera.

  1. The patient who leaves the building. Injected at half past eight, told to come back at eleven, arrives at one. Give the return time in writing, on paper, in Bangla, take a phone number, and where the uptake is short enough, keep them in the department.
  2. One room doing two jobs. If injections happen in the imaging room, injections and acquisitions compete for the same space all morning. A separate injection position, even a screened corner with a chair and a mobile shielded barrier, usually buys more throughput than a second detector.
  3. Inpatient transport. The porter arrives when the porter arrives. Book ward patients into the slots you can afford to lose, and keep an outpatient nearby who can be brought forward.
  4. SPECT slots priced as planar slots. A SPECT acquisition with the arms positioned, the orbit set and processing to follow is not a whole body sweep. Time it honestly in the template or every afternoon runs late.
  5. The camera going down. Utilisation calculations rarely include unplanned downtime, and in Bangladesh the response time in the service contract is often what decides how many days a year the department loses, as set out in preventive maintenance and service contracts.

Before any of this becomes an argument for a second camera, measure it. For one working week, log the time each acquisition starts and ends and the reason for every gap longer than ten minutes. The result is usually uncomfortable and useful in equal measure: the detector is idle for a large part of the day, and the reasons are the injection room, the technologist and the decay curve rather than the hardware. Whether a second detector is the right answer is worked through in single-head or dual-head. Do the week of logging first. It costs nothing, and it has talked more than one committee out of an unnecessary purchase.

Back to all Insights